Briggs Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Sell
207
-77
-27% -$78.7K 0.23% 52
2026
Q1
$261K Hold
284
0.28% 42
2025
Q4
$305K Buy
+284
New +$272K 0.33% 34

Other funds holding LLY

Briggs Wealth Management's LLY Position: Q2 2026 in Review

Briggs Wealth Management reduced its Eli Lilly (LLY) stake by 27% in Q2 2026, selling an estimated $78.7K and leaving 207 shares worth $248K. The position accounts for 0.23% of the portfolio, ranked #52.

Briggs Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $305K in Q4 2025. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Briggs Wealth Management held 207 shares of Eli Lilly worth $248K as of Q2 2026.
  • Briggs Wealth Management sold 77 Eli Lilly shares in Q2 2026, an estimated $78.7K.
  • Eli Lilly made up 0.23% of Briggs Wealth Management's portfolio in Q2 2026, its #52 holding.
  • Briggs Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Briggs Wealth Management's Eli Lilly position peaked at $305K in Q4 2025.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Briggs Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.